Oncolytic VSV-IL-2 has enhanced anticancer vaccination adjuvant abilities. [PDF]
Mullins-Dansereau V +8 more
europepmc +1 more source
Tropism Profiling of Lentiviral Vector Pseudotypes in Diverse Brain Tumor Models. [PDF]
Andersen JK +4 more
europepmc +1 more source
Pioneering Role of T.C. Merigan in the Treatment of Various Virus Infections. [PDF]
De Clercq E.
europepmc +1 more source
Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems. [PDF]
Shrivastava-Ranjan P +10 more
europepmc +1 more source
Histone deacetylase 6 inhibits STING-dependent antiviral immunity via site-specific deacetylation. [PDF]
Qu M +11 more
europepmc +1 more source
Functional analysis and verification of GYG2 in oncolytic virus-infected glioma. [PDF]
Dong Y +5 more
europepmc +1 more source
Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype. [PDF]
Hatami J +14 more
europepmc +1 more source
Tradeoffs in viral fitness driven by alternative entry pathways. [PDF]
Carrascosa-Sàez M +2 more
europepmc +1 more source
Context-Specific Diversity of Antimicrobial Functions of Interferon-Stimulated Genes. [PDF]
Harioudh MK, Sarkar SN.
europepmc +1 more source

